Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer 'Drug Discovery Enterprise'
Premium
The MOSAIC research coalition brings together Owkin, NanoString, and European and US institutions to create a massive spatial omics dataset in pursuit of novel cancer biomarkers
The company is leveraging immunogenic peptides created by cancer cells as diagnostic and vaccine targets in both humans and dogs.
The company sees a clearer path to clinical validation and reimbursement through molecules that more directly measure how drugs affect the brain.
Cell-Free DNA Shows Promise as Cardiotoxicity Biomarker in HER2-Positive Breast Cancer Patients
The findings, published in JAMA Cardiology, show the role of cardiomyocyte-derived cell free DNA in predicting risk of post-chemotherapy cardiac problems.
The team measured changes in DNA methylation in more than 1,200 patients to create an algorithm to determine kidney function and predict decline.